Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

1.

Alcoholic liver disease - the extent of the problem and what you can do about it.

Hazeldine S, Hydes T, Sheron N.

Clin Med. 2015 Apr;15(2):179-85. doi: 10.7861/clinmedicine.15-2-179.

PMID:
25824072
2.

Commentary: Minimum unit price--how the evidence stacks up.

Sheron N, Eisenstein K.

BMJ. 2014 Jan 7;348:g67. doi: 10.1136/bmj.g67. No abstract available.

PMID:
25489933
3.

Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis.

Williams R, Aspinall R, Bellis M, Camps-Walsh G, Cramp M, Dhawan A, Ferguson J, Forton D, Foster G, Gilmore I, Hickman M, Hudson M, Kelly D, Langford A, Lombard M, Longworth L, Martin N, Moriarty K, Newsome P, O'Grady J, Pryke R, Rutter H, Ryder S, Sheron N, Smith T.

Lancet. 2014 Nov 29;384(9958):1953-97. Review. No abstract available. Erratum in: Lancet. 2014 Dec 20;384(9961):2212.

PMID:
25433429
4.

Impact of minimum price per unit of alcohol on patients with liver disease in the UK.

Sheron N, Chilcott F, Matthews L, Challoner B, Thomas M.

Clin Med. 2014 Aug;14(4):396-403. doi: 10.7861/clinmedicine.14-4-396.

PMID:
25099842
5.

Current treatment options for alcohol-related liver disease.

Hazeldine S, Sheron N.

Curr Opin Gastroenterol. 2014 May;30(3):238-44. doi: 10.1097/MOG.0000000000000065. Review.

PMID:
24662843
6.

Feasibility of detection and intervention for alcohol-related liver disease in the community: the Alcohol and Liver Disease Detection study (ALDDeS).

Sheron N, Moore M, O'Brien W, Harris S, Roderick P.

Br J Gen Pract. 2013 Oct;63(615):e698-705. doi: 10.3399/bjgp13X673711.

7.

Hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease.

Aravinthan A, Pietrosi G, Hoare M, Jupp J, Marshall A, Verrill C, Davies S, Bateman A, Sheron N, Allison M, Alexander GJ.

PLoS One. 2013 Sep 23;8(9):e72904. doi: 10.1371/journal.pone.0072904. eCollection 2013.

8.

Acceptability of screening for early detection of liver disease in hazardous/harmful drinkers in primary care.

Eyles C, Moore M, Sheron N, Roderick P, O'Brien W, Leydon GM.

Br J Gen Pract. 2013 Aug;63(613):e516-22. doi: 10.3399/bjgp13X670642.

9.

Alcohol marketing: grooming the next generation: children are more exposed than adults and need much stronger protection.

Hastings G, Sheron N.

BMJ. 2013 Feb 28;346:f1227. doi: 10.1136/bmj.f1227. No abstract available.

PMID:
23449659
10.

Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries.

Moodie R, Stuckler D, Monteiro C, Sheron N, Neal B, Thamarangsi T, Lincoln P, Casswell S; Lancet NCD Action Group.

Lancet. 2013 Feb 23;381(9867):670-9. doi: 10.1016/S0140-6736(12)62089-3. Epub 2013 Feb 12. Review.

PMID:
23410611
11.

Developing a 'traffic light' test with potential for rational early diagnosis of liver fibrosis and cirrhosis in the community.

Sheron N, Moore M, Ansett S, Parsons C, Bateman A.

Br J Gen Pract. 2012 Sep;62(602):e616-24. doi: 10.3399/bjgp12X654588. Erratum in: Br J Gen Pract. 2013 Aug;63(613):406.

12.

Sexual assault and coincident alcohol use in attendees at a genitourinary medicine clinic in the south of England.

Blume A, Standerwick K, Tucker L, Harris S, Sheron N.

Int J STD AIDS. 2012 Feb;23(2):115-9. doi: 10.1258/ijsa.2011.011149.

PMID:
22422686
13.

Projections of alcohol-related deaths in England and Wales--tragic toll or potential prize?

Sheron N, Gilmore I, Parsons C, Hawkey C, Rhodes J.

Lancet. 2012 Feb 25;379(9817):687-8. doi: 10.1016/S0140-6736(12)60244-X. Epub 2012 Feb 20. No abstract available.

PMID:
22353260
14.

Structural and functional uncoupling of liver performance in the Fontan circulation.

Guha IN, Bokhandi S, Ahmad Z, Sheron N, Cope R, Marshall C, Veldtman G.

Int J Cardiol. 2013 Mar 20;164(1):77-81. doi: 10.1016/j.ijcard.2011.06.062. Epub 2011 Jul 23.

PMID:
21788088
15.

Social inequalities in alcohol-related adult mortality by National Statistics Socio-economic Classification, England and Wales, 2001-03.

Siegler V, Al-Hamad A, Johnson B, Wells C, Sheron N.

Health Stat Q. 2011 Summer;(50):4-39. doi: 10.1057/hsq.2011.7.

PMID:
21647087
16.

Priority actions for the non-communicable disease crisis.

Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, Baugh V, Bekedam H, Billo N, Casswell S, Cecchini M, Colagiuri R, Colagiuri S, Collins T, Ebrahim S, Engelgau M, Galea G, Gaziano T, Geneau R, Haines A, Hospedales J, Jha P, Keeling A, Leeder S, Lincoln P, McKee M, Mackay J, Magnusson R, Moodie R, Mwatsama M, Nishtar S, Norrving B, Patterson D, Piot P, Ralston J, Rani M, Reddy KS, Sassi F, Sheron N, Stuckler D, Suh I, Torode J, Varghese C, Watt J; Lancet NCD Action Group; NCD Alliance.

Lancet. 2011 Apr 23;377(9775):1438-47. doi: 10.1016/S0140-6736(11)60393-0. Epub 2011 Apr 5.

PMID:
21474174
17.

Alcohol marketing to children.

Hastings G, Sheron N.

BMJ. 2011 Mar 24;342:d1767. doi: 10.1136/bmj.d1767. No abstract available.

PMID:
21436118
18.

Direct measurement of porto-systemic gradient in a failing Fontan circulation.

Velpula M, Sheron N, Guha N, Salmon T, Hacking N, Veldtman GR.

Congenit Heart Dis. 2011 Mar-Apr;6(2):175-8. doi: 10.1111/j.1747-0803.2010.00451.x. Epub 2011 Mar 1.

PMID:
21356034
19.

Projections of alcohol deaths--a wake-up call.

Sheron N, Hawkey C, Gilmore I.

Lancet. 2011 Apr 16;377(9774):1297-9. doi: 10.1016/S0140-6736(11)60022-6. Epub 2011 Feb 19. No abstract available.

PMID:
21334738
20.

Drugs and harm to society.

Hawkey C, Rhodes J, Gilmore I, Sheron N.

Lancet. 2011 Feb 12;377(9765):554; author reply 555. doi: 10.1016/S0140-6736(11)60198-0. No abstract available.

PMID:
21315942
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk